Further, treatment of mice growing PDX triple-negative breast cancer (TNBC) cells with M2I-1 stalled tumor growth, reduced APC substrate levels, and induced PARP cleavage and histone H3 acetylation. This evidence concerns the gene APC and triple-negative breast carcinoma.